Diabetes drugs in the incretin mimetic class, such as Tradjenta, have been linked to severe side effects like pancreatitis, pancreatic cancer, rhabdomyolysis, and more.
Need a Texas Tradjenta Lawyer? Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged. If you or a loved one was diagnosed with a severe side effect, you should contact our lawyers immediately. You may be entitled to compensation by filing a lawsuit.
FDA Evaluating Rhabdomyolysis Risk
The FDA is evaluating a potential signals of a serious risk and new safety information linking DPP4 diabetes drugs and rhabdomyolysis. This potentially life-threatening kidney side effect was identified by the FDA Adverse Event Reporting System (FAERS) between April and June 2017.
Tradjenta and Pancreatic Cancer
Tradjenta (linagliptin) belongs to a class of diabetes drugs called incretin mimetics. These drugs mimic digestive hormones called incretins that stimulate the pancreas to make more insulin, which lowers blood-sugar levels.
The problem is that over-stimulating the pancreas can lead to severe side effects, such as inflammation (pancreatitis). The FDA has already issued warnings about hemorrhagic and necrotizing pancreatitis for people on incretin mimetics.
Over time, chronic pancreatitis increases the risk of pancreatic cancer — one of the deadliest types of cancer. In 2010, Gastroenterology published a study confirming an increased risk of pancreatic cancer. In 2013, Diabetes published a study in which researchers found evidence of pre-cancerous growths called pancreatic duct metaplasia.
The FDA opened an investigation and issued a Safety Communication about pancreatic side effects of Tradjenta in March 2013. However, the agency did not ask drug-makers to update warning labels.
Individual Lawsuits Consolidated in Federal MDL
Federal judges have consolidated over 750 individual lawsuits involving diabetes drugs in the incretin mimetic class, including Kazano. The Multi-District Litigation (MDL No. 2452) is located in the U.S. District Court for the Southern District of California.
What is the problem?
The Clark Firm, LLP is nationally recognized as a class action law firm in Texas, but our trial lawyers are not filing a Tradjenta class action. Instead, we are filing individual lawsuits. We are now accepting cases involving severe side effects, such as pancreatic cancer.
About Class Actions
Class actions are a good way to resolve a lot of similar legal claims in one lawsuit. The outcome for everyone who joins the class action is depends on the “class representative,” and any compensation is divided equally.
Why Our Law Firm is Filing Individual Lawsuits as Opposed to a Class Action
The disadvantage of a class action is that members may have to accept a “low-ball” settlement, high attorneys’ fees, or a payout that does not cover their expenses. This is why it is unlikely that a class action will be filed for people who developed pancreatic cancer.
Instead, our attorneys are filing individual lawsuits. We focus on helping people with the most severe injuries from unsafe medications file lawsuits against pharmaceutical companies. If you were injured, you could be entitled to compensation for your medical expenses — and more.
Need a Tradjenta Lawyer in Texas?
Collen A. Clark is a true advocate for his clients and is passionate about helping Texans that have been injured or wronged.
Collen’s amazing success in the courtroom and well known dedication to his clients has earned him the recognition of his peers as one of The Top Trial Lawyers in Texas.”
The Clark Firm has assembled a team of trial lawyers with more than 100 years experience, participation in over 600 jury trials and $260 million in verdicts and/or settlements. Please use the form below to contact our Texas Tradjenta lawyers for a free lawsuit review.